Larsen JR, Martin MR, Martin JD, et al., 2020, Modeling the Onset of Symptoms of COVID-19. Front Public Health, 8:473. DOI: 10.3389/fpubh.2020.00473.

Paces J, Strizova Z, Smrz D, et al., 2020, COVID-19 and the Immune System. Physiol Res, 69:379–88. DOI: 10.33549/physiolres.934492.

McGonagle D, Sharif K, O’Regan A, et al., 2020, The Role of Cytokines Including Interleukin-6 in COVID-19 Induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev, 19:102537. DOI: 10.1016/j.autrev.2020.102537.

Roshanravan N, Seif F, Ostadrahimi A, et al., 2020, Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review. Arch Med Res, 51:608–12. DOI: 10.1016/j.arcmed.2020.06.012

Li SW, Yang TC, Wan L, et al., 2012. Correlation between TGF-b1 Expression and Proteomic Profiling Induced by Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease. Proteomics, 12:3193–205. DOI: 10.1002/pmic.201200225.

Wang CY, Lu CY, Li SW, et al., 2017, SARS Coronavirus Papain-Like Protease Up-Regulates the Collagen Expression Through Non-Samd TGF-b1 Signaling. Virus Res, 235:58–66. DOI: 10.1016/j.virusres.2017.04.008.

Li SW, Wang CY, Jou YJ, et al., 2016, SARS Coronavirus Papain-Like Protease Induces Egr-1-Dependent Up-Regulation of TGF-b1 Via ROS/p38 MAPK/STAT3 Pathway. Sci Rep, 6:25754. DOI: 10.1038/srep25754.

Chen W, 2020, A Potential Treatment of COVID-19 with TGF-b Blockade. Int J Biol Sci, 16:1954–5. DOI: 10.7150/ijbs.46891.

Ferner RE, Aronson JK, 2020. Remdesivir in COVID-19. BMJ, 369:m1610. DOI: 10.1136/bmj.m1610.

Zhang L, Yu D, 2019, Exosomes in Cancer Development, Metastasis, and Immunity. Biochim Biophys Acta Rev Cancer, 1871:455–68. DOI: 10.1016/j.bbcan.2019.04.004.

Thakur BK, Zhang H, Becker A, et al., 2014, Double-Stranded DNA in Exosomes: A Novel Biomarker in Cancer Detection. Cell Res, 24:766–9. DOI: 10.1038/cr.2014.44.

Valadi H, Ekström K, Bossios A, et al., 2007, Exosome-Mediated Transfer of mRNAs and microRNAs is a Novel Mechanism of Genetic Exchange between Cells. Nat Cell Biol, 9:654–9. DOI: 10.1038/ncb1596.

Milman N, Ginini L, Gil Z, 2019, Exosomes and their Role in Tumorigenesis and Anticancer Drug Resistance. Drug Resist Updat, 45:1–12. DOI: 10.1016/j.drup.2019.07.003.

Pfeffer SR, Grossmann KF, Cassidy PB, et al., 2015, Detection of Exosomal miRNAs in the Plasma of Melanoma Patients. J Clin Med, 4:2012–27. DOI: 10.3390/jcm4121957.

Al-Nedawi K, Meehan B, Micallef J, et al., 2008, Intercellular Transfer of the Oncogenic Receptor EGFRvIII by Microvesicles Derived from Tumour Cells. Nat Cell Biol, 10:619–24. DOI: 10.1038/ncb1725.

Barberis E, Vanella VV, Falasca M, et al., 2021, Circulating Exosomes are Strongly Involved in SARS-CoV-2 Infection. Front Mol Biosci, 8:632290. DOI: 10.3389/fmolb.2021.632290.

Tran MT, 2021, Overview of Ca2+ Signaling in Lung Cancer Progression and Metastatic Lung Cancer with Bone Metastasis. Explor Target Antitumor Ther, 2:249–65. DOI: 10.37349/etat.2021.00045.

Faict S, Muller J, de Veirman K, de Bruyne E, et al., 2018, Exosomes Play a Role in Multiple Myeloma Bone Disease and Tumor Development by Targeting Osteoclasts and Osteoblasts. Blood Cancer J, 8:105. DOI: 10.1038/s41408-018-0139-7.

Zhang J, Wu J, 2021, The Potential Roles of Exosomal miR-214 in Bone Metastasis of Lung Adenocarcinoma. [Hypothesis and Theory]. Front Oncol, 10:3341. DOI: 10.3389/fonc.2020.611054.

Li FX, Liu JJ, Xu F, et al., 2019, Role of Tumor-Derived Exosomes in Bone Metastasis. Oncol Lett, 18:3935–45. DOI: 10.3892/ol.2019.10776.

Eisenblaetter M, Flores-Borja F, Lee JJ, et al., 2017, Visualization of Tumor-Immune Interaction-Target-Specific Imaging of S100A8/A9 Reveals Pre-Metastatic Niche Establishment. Theranostics, 7:2392–401. DOI: 10.7150/thno.17138.